Gina Kolata

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Through sheer determination, Neena Nizar has become the first patient in a clinical trial testing a treatment for her disease — one so rare it affects just 30 people worldwide.

The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.

The vast majority of cases begin in the fallopian tubes — and removing them can reduce the risk by nearly 80 percent.

A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.

How does it compare to statins? Should you take it? And how much does it cost?

The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.

The condition that killed Senator Lindsey Graham is deadly, sudden and difficult to treat — “like a knife to the back,” one expert said.

Artificial intelligence programs can spot patterns in electrocardiograms that humans miss. Now, one program is going to be widely available — for free — to doctors.

Her decades of work on Huntington’s disease helped lead to the creation of a genetic test for the devastating condition. Why didn’t she take it herself?